Monique van Scherpenzeel

Laura C . Tegtmeyer, Stephan Rust, Ph.D., Monique van Scherpenzeel, Ph.D., Bobby G. Ng, B.S., Marie-Estelle Losfeld, Ph.D., Sharita Timal, B.S., Kimiyo Raymond, M.D., Ping He, Ph.D., M.D., Mie Ichikawa, M.S., Joris Veltman, Ph.D., Karin Huijben, B.Sc., Yoon S. Shin, Ph.D., Vandana Sharma, Ph.D., Maciej Adamowicz, Ph.D., Martin Lammens, Ph.D., Janine Reunert, Ph.D., Anika Witten, Ph.D., Esther Schrapers, Gert Matthijs, Ph.D., Jaak Jaeken, M.D., Ph.D., Daisy Rymen, M.D., Tanya Stojkovic, M.D., Ph.D.D.D.D., Ph.D., Elzbieta Czarnowska, Ph.D., Monique Piraud, Ph.D., Teodor Podskarbi, M.D., Charles A.

The two 2 cases which were observed after dose 1 were less than the minimum number of required situations , therefore the log-likelihood ratio was not calculated. In comparison with the historical price of intussusception in the VSD people, the attributable threat of intussusception for infants receiving the monovalent rotavirus vaccine was 5.3 cases per 100,000 infants receiving the two doses of vaccine. We performed a cluster analysis of most intussusception cases in the emergency division or hospital setting within 30 days after monovalent rotavirus vaccination. We identified a substantial cluster in the interval 3 to 6 times after such vaccination . Comparison with Pentavalent Rotavirus Vaccine Our updated analysis of data regarding pentavalent rotavirus vaccination from May 2006 through March 2013 showed zero significant increased threat of intussusception .